American Journal of Respiratory Cell and Molecular Biology · 2009 · 15 citations · 36 references
MedicineOncologyPharmacologyCancer PharmacologyCell SignalingMolecular OncologyCancer Cell SignalingLung CancerLung Cancer ChemopreventionP21 RegulationPeroxisome Proliferator Receptor SignalingPeroxisome Proliferator-activated Receptor Gamma AgonismPeroxisome Proliferator-activated Receptor Gamma RegulationPeroxisome Proliferator-activated Receptor SignalingPeroxisome Proliferator-activated ReceptorsTobacco Carcinogenesis
Among the carcinogenic chemicals of cigarette smoking, 4-(methylnitrosamino-1-(3-pyridyl)-1-butanone (NNK) is the most potent. The activation of peroxisome proliferator-activated receptor (PPAR)gamma can arrest the growth of lung cancer. We hypothesized that PPARgamma activation inhibits NNK-mediated proliferation of lung cancer cells. PPARgamma expression was increased in 94.7% human lung cancer tumor tissues, compared with their paired corresponding nontumor tissues. PPARgamma was also found to be abundant in all the lung cancer cell lines tested. Troglitazone dose-dependently inhibited the NNK-mediated proliferation of lung cancer cells that expressed PPARgamma. Troglitazone blocked NNK-induced up-regulation of HO-1, Bcl-2, and c-IAP2, and recovered Bad activity that was suppressed by NNK. NNK promoted the nuclear p21, whereas troglitazone increased cytosolic p21. Troglitazone increased PPARgamma transcriptional activity in NNK-treated cells and a PPARgamma dominant-negative inhibitor completely suppressed the action of troglitazone, indicating that troglitazone against NNK was PPARgamma-dependent. The findings reveal a novel molecular pathway of PPARgamma activation against cigarette smoking-related lung cancer.
36
Differentiation and reversal of malignant changes in colon cancer through PPARγ
Pasha Sarraf, Elisabetta Mueller, Daniel M. Jones et al. · Nature Medicine · 1998 · 973 citations
Terminal Differentiation of Human Breast Cancer through PPARγ
Elisabetta Mueller, Pasha Sarraf, Peter Tontonoz et al. · Molecular Cell · 1998 · 844 citations · Full text
Peter Tontonoz, Samuel Singer, Barry M. Forman et al. · Proceedings of the National Academy of Sciences · 1997 · 649 citations
Medicine, Oncology, Pharmacology +15